chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She is having numbness and tingling in her arm that they gave the dose. She also experienced it in her ''quadrants'' and part on her leg as well as in her other arm/The numbness and tingling or the left, sorry the left; She is having numbness and tingling in her arm that they gave the dose. She also experienced it in her ''quadrants'' and part on her leg as well as in her other arm/The numbness and tingling or the left, sorry the left; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A 26 year-old female patient received bnt162b2 (BNT162B2), administration date 30Nov2021 18:00 (Lot number: FG3527) at the age of 26 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PARAESTHESIA (non-serious), HYPOAESTHESIA (non-serious) all with onset 01Dec2021, outcome "unknown" and all described as "She is having numbness and tingling in her arm that they gave the dose. She also experienced it in her ''quadrants'' and part on her leg as well as in her other arm/The numbness and tingling or the left, sorry the left". Therapeutic measures were not taken as a result of paraesthesia, hypoaesthesia.  Follow-up (08Dec2021): Follow-up attempts are completed. No further information is expected.
Chills at about 11:00AM on 3/1/19, followed by fever and headache about 30 minutes later, lasting 36 hours (symptoms eased at 2:00PM on 3/3/19 ... one 200mg tablet of ibuprofen every 4-6 hours helped reduce but eradicate the symptoms.
Information has been received from a physician's assistant concerning a 19 year old female pt, who in approximately October 2000 was vaccinated with a first dose of hep B vaccine recombinant. A few hours later, the pt developed lower abdominal cramping that resolved after a few hours. Unspecified medical attention was sought, but no intervention was required. No further info is available.
Information has been received from a physician concerning a female (age unknown), who, on an unspecified date, was vaccinated intramuscularly with a 0.5mL third dose of Gardasil. Subsequently, five days after receiving the vaccination the patient experienced "nausea, vomiting, and fever (flu like symptoms)". The patient sought unspecified medical attention. At the time of the report, the patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
Chills, Headache, Body Ache, Slight Fever.  Took Advil to lessen the symptoms.  Still not feeling 100% on day 2.
(Have never had the slightes reaction to flu shot before this, including years of hi-dose.) Chills with uncontrollable shaking, severe joint and muscle pain, headache, weakness, heavy limbs, night fever. (Brother had same reaction to hi-dose this yr despite never a problem before.)
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 39K20-2) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 04-Dec-2020 and the estimated date of delivery was 10-Sep-2021. On 24-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fifth week of the pregnancy.  On 24-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Jan-2021, Pregnancy: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not reported . Treatment history was not reported .  This is a case of product exposure during pregnancy with no associated AEs for this 33-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jan-2021: Pregnancy form attached contains, LMP, Due date, Gestation period , Pregnancy test details On 06-Jan-2021: TCR received contains Email address of patient and consented to follow up with her after her due date.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 33-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
fatigue, muscle pain in left arm, muscle pain and stiffness in neck and upper back, headache, chills, poor circulation in hands and feet (could not get warm), pain in lymph nodes (under arms, especially left, started 2/18)
COVID Diagnoses After Vaccination; Nasal congestion; Cough; Diarrhea; Loss of taste; Chills; Nausea; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of COVID-19 (COVID Diagnoses After Vaccination) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced COVID-19 (COVID Diagnoses After Vaccination) (seriousness criterion hospitalization). On an unknown date, the patient experienced NASAL CONGESTION (Nasal congestion), COUGH (Cough), DIARRHOEA (Diarrhea), AGEUSIA (Loss of taste), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, COVID-19 (COVID Diagnoses After Vaccination), NASAL CONGESTION (Nasal congestion), COUGH (Cough), DIARRHOEA (Diarrhea), AGEUSIA (Loss of taste), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, SARS-CoV-2 test: positive (Positive) Source of sample- Nasopharyngeal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Relevant concomitant medications were not reported.  Treatment information included Monoclonal antibody therapy as bamlanivimab infusion for the virus start on 19 Jan 2021.  Company Comment: This case concerns a 78-year-old female with a serious unexpected event of COVID-19, and nonserious unexpected nasal congestion, cough, diarrhea, ageusia, and nonserious expected chills, nausea. Event onset with unknown latency after first dose mRNA-1273. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Follow-up information included adverse events (chills, cough, nausea, diarrhea, nasal congestion and loss of taste), hospitalization confirmation, laboratory exam performed date and treatment information as bamlanivimab infusion.; Sender's Comments: This case concerns a 78-year-old female with a serious unexpected event of COVID-19, and nonserious unexpected nasal congestion, cough, diarrhea, ageusia, and nonserious expected chills, nausea. Event onset with unknown latency after first dose mRNA-1273. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Approximately 5-7 days after the vaccination he started having shortness of breath progressively getting worse. He was admitted to hospital on 1/27/2016 with hypoxia and was then transferred to ICU on 1/29/16 after bronchoscopy. He remains in ICU currently. All work up has been negative in regard to diagnosis.
Pt recv vax on 11/11/98; 10 min post vax pt exp chest tight & dizziness
Rash and itching at sire, spread to shoulder. Took antihistamine with resolution of symptoms within 90 minutes.
Injection site hurt longer than any previous flu shot and muscle continues to hurt especially with movement of arm, with some restriction of movement and decreased use of arm due to pain.
p/recv vax pt exp burning in antecubital space, chest & same arm of inject site, later tender lymph nodes under arm some 5days later.
Case number PHEH2016US023471, is an initial spontaneous report received from a nurse on 13 Sep 2016. This report refers to a 56 years old patient of unknown gender. Past medical history and concomitant medications were not reported. The patient was vaccinated with one single dose of FLUVIRIN (batch number: 1515701) at a dose of 0.5 ml, intramuscularly, into right arm on 12 Jan 2016. On 12 Jan 2016, FLUVIRIN MDV that had been exposed to 8 to 10 temperature excursion was administered to patient. No adverse event was reported following this medication error (incorrect product storage). The case was assessed as non-serious by the nurse.
I was having chest pains after a gardening endeavor. I tried to take to a shower but had to cut it short but started to feel clammy, short of breath. I drove to a friend's house and asked him to drive me to the emergency room. Upon arrival to the emergency room, they ran an EKG, blood work, echocardiogram. I was given two choices to wait four days as they did not have anyone there to help with my episode to be transported to the hospital locally. Once in the hospital, they ran the same test found that I had 99% blockage that I had in 2017. The cardiologist stated the stents that were originally put in were too small. He cleaned the vessel, implanted a larger stent, let me know my other vessels were clean and I should be able to live a long healthy life. I am currently partway through cardiopulmonary rehab.
This spontaneous report as received from a pharmacist refers to 2 patients of unknown age and gender. The patients' medical history, current conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored dose of GARDASIL (dose, frequency, route, lot number and expiry date were not reported) or GARDASIL 9 (dose, frequency, route, lot number and expiry date were not reported). The vaccines were exposed to a temperature frame of 32 Fahrenheit to 34 Fahrenheit for an unspecified duration. Reporter stated that consumer asked pharmacist's advice on how to decide on the possible need for revaccination, as the unspecified physician who administered the vaccines did not provided any guidance to her. There was no product quality complaint involved. Additional information is not expected as the reporter has not provided consent to contact.
Patient / received Boostrix / after / exposed to a temperature of negative 12 degrees Celsius; This case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a 12-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 9L39Z, expiry date 8th October 2021) for prophylaxis.   Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 30th June 2021, the patient received Boostrix (intramuscular) and Boostrix Pre-Filled Syringe Device. On 30th June 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The nurse reported that, the patient inadvertently received Boostrix through route in the left deltoid after the Boostrix was exposed to a temperature of negative 12 degree Celsius, which led to incorrect storage of drug. The reporter consented to follow up.
Approximately 10 hours after receiving ROTATEQ, PENTACEL, and PREVNAR the pt. had vomiting and copious diarrhea that resulted in the office the next day with dehydration and inability to take PO fluids. The pt. was then admitted to the hospital for IV fluids.
Chills the night of the 17th, Fever, chills, body aches, headache on the 18th day.  Hives began afternoon of the 18th on chest. Hives/rash all over the body on the 19th.
Severe swelling of my arm from the elbow to the shoulder.  Extremely hot to touch and painful...could not raise my arm. Redness, skin discolored to red with bumps. I called the on call physician to report problem. I took a Benadryl that night. Swelling has gone done some but this is the third night for swelling and taking Benadryl. The swelling is now moving down my arm and is below my elbow and the upper arm has gotten somwhat better. No telling where it is going next but now it is below my elbow and it was not there the past two days. I will go back to Dr. to show her if I see it getting worse or more serious. But right now there does not seem to be anything anyone can do but I can take Benadryl and hope it goes away. Never had a reaction to any vaccine or any medicine before this.
Bilateral large swollen lymph nodes under the neck; Booster shot was administered as a full dose; Patient felt groggy/sleepy; Pain in arm of injection/pain in left arm during 2 days after injection; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Patient felt groggy/sleepy), PAIN IN EXTREMITY (Pain in arm of injection/pain in left arm during 2 days after injection), LYMPHADENOPATHY (Bilateral large swollen lymph nodes under the neck) and ACCIDENTAL OVERDOSE (Booster shot was administered as a full dose) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product INFLUENZA VACCINE (FLU VACCINE VII) for an unknown indication.    Concurrent medical conditions included Type 2 diabetes mellitus (Diabetes type 2 started 6 years ago) since 2016 and Hypertension. Concomitant products included METFORMIN for Diabetes, OMEPRAZOLE for GERD, SIMVASTATIN for Hypertension, HYDROCHLOROTHIAZIDE for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Aug-2021, the patient received dose of INFLUENZA VACCINE (FLU VACCINE VII) (unknown route) 1 dosage form. On 26-Aug-2021, the patient experienced SOMNOLENCE (Patient felt groggy/sleepy), PAIN IN EXTREMITY (Pain in arm of injection/pain in left arm during 2 days after injection) and ACCIDENTAL OVERDOSE (Booster shot was administered as a full dose). On 21-Feb-2022, the patient experienced LYMPHADENOPATHY (Bilateral large swollen lymph nodes under the neck). On 27-Aug-2021, SOMNOLENCE (Patient felt groggy/sleepy) had resolved. On 28-Aug-2021, PAIN IN EXTREMITY (Pain in arm of injection/pain in left arm during 2 days after injection) had resolved. At the time of the report, LYMPHADENOPATHY (Bilateral large swollen lymph nodes under the neck) had not resolved and ACCIDENTAL OVERDOSE (Booster shot was administered as a full dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient experienced a similar event pain in the arm which lasted for 2 days after flu shot. No treatment was given for immediate symptoms after vaccination but on 21-Feb-2022, Dentist prescribed antibiotics for swollen lymph nodes, because it could be due to an infection. Reporter and patient would visit doctor on 28-Feb-2022 for large swollen lymph nodes.
Seven days after I received my first vaccine the area that I was inoculated in became red, inflamed, itchy, and I started a fever.  The red, inflamed and itchy lasted for 6 days.  The fever lasted one day.  Then my are bruised and stayed bruised for 15 days, it is still bruised currently (21 days after vaccine.  I still get a shooting pain every so often in the vaccine area.  I also have gotten tingling in both hands and back.
Redness, hives, Left arm and Avilla, nausea, headache 2-3 days, malaise. Seen 11/20/06 at clinic  and patient is taking Zyrtec 10mg every ten hours. Symptoms: Resolving.
Denied allergies prior to vaccination. Following shot c/o "warm feeling, lips numb, throat feels funny" inj. site appears red & raised. Ice applied vitals taken. Pt took Benadryl 25 mg.  States "I feel fine now" 15 minutes. Family drove her home. Also states she has had reactions to latex in past.
9 days s/p 2nd vaccine, in the arm that received the vaccine, noted the left breast was twice the size of the right breast. No redness, tenderness, not nipple discharge. The left axcilla soft, nontender, no palpable lymph nodes noted. 10 days s/p 2nd vaccine, left breast, still enlarged, then tender to palpation. Injection site is fine. No fevers, chills, nor sweats. Warm compressed applied to left axcilla, keeping left arm in motion, continuing to try to support the left breast.
This spontaneous report was received from a healthcare worker and refers to a unspecified number of patients of unknown age and gender. In approximately 2016, the patients were orally vaccinated with improperly stored doses of ROTATEQ (dose and frequency were not reported , lot # L037574 with expiration date: 01-JUL-2016). No adverse effects were reported. Administered vaccine experienced the temperature excursion at 31.5 degrees Fahrenheit for 2 minutes on 10-MAY-2016. Data logger was involved. There was no previous temperature excursion. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous case, received from a pharmacist on 15-Oct-2018, (initial and follow-up 1 combinedly processed), concerns a 34-year-old, adult male patient. On an unspecified date, FLUCELVAX QIVc was stored at a maximum temperature of 56 F for 8 hours following a power outage. On 14-Oct-2018, the patient was administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 252668 and expiry date: 30-Jun-2019) which underwent temperature excursion. No adverse event was reported. The reporter assessed the case as non-serious. This case 201804535 was cross linked to the case 201804533 (original case) reported by the same reporter.
When I caught COVID-19 I felt sick, run down, and tired. I had some chest congestion. It felt like something was wrong. For a couple of days I felt sick. I was prescribed PAXLOVID. A few days after taking it my chest congestion cleared up, but I had a lingering chest congestion about 4 or 5 days after that then everything felt pretty normal. Within a period of 2 days after taking PAXLOVID I was feeling better. Within 4 days I felt a little more better.
Initial report was received 15 June 2011 from a health care professional. This case represents one of a cluster of three patients who experienced adverse events after receiving ADACEL, lot number C3898BA. The other two patients have been captured in case numbers 2011-03461 and 2011-03462. A 46-year-old male patient who had a history of hypertension and allergy to penicillin, had received a first dose intramuscular left deltoid injection of ADACEL, lot number C3898BA and an intramuscular right deltoid injection of Hepatitis B vaccine (manufacturer GlaxoSmithKline, lot number AHBUB944BB) on 01 June 2011, and one day later, he developed a reddened, warm to touch area that was approximately the size of a grapefruit. He was evaluated by a health care professional who diagnosed the symptoms as cellulitis. Corrective treatments were not reported. The patient had not received any other vaccinations within four weeks prior to receiving ADACEL and Hepatitis B vaccines. At the time of the report, the event was not completely resolved. Outcome was not recovered. The reporter for this case is the same as case number 2011-03460.
Patient states that she has not been able to move her arm ever since she received the vaccine. She visited the MD and was told to watch it. If no improvement she is to have a follow up.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 15-NOV-2013, the patient was vaccinated with GARDASIL lot # 670050/1229AA. It was reported that the patient received GARDASIL on 15-NOV-2013 which was expired on 12-NOV-2013 (Lot number was reported as 670050/1229AA). No adverse event reported. Additional information has been requested.
1:00AM-Severe chills/shaking 3:00AM-Temp 100.4, nausea, diarrhea. Took Naproxen 220mg at this time 4:00AM-Temp in the 99.0 range, chills/shaking subsided 12:00PM-Pt stated back to normal self
Speechless; Brain fog; Anxiety attack; Feel awful.; Fever; Muscle ache; Chills; Tingling in head and lowered back; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old, non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0162) via an unspecified route of administration on 09Apr2021 at 13:45 (at an age of 40-years-old) as single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within 4 weeks prior to COVID vaccine. The patient did not receive any concomitant medications.  On 16Apr2021, the patient had tingling in head and lowered back, chills, fever, speechless, brain fog, anxiety attack, muscle ache symptoms were on going for a week, felt awful. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of tingling in head and lowered back, chills, fever, speechless, brain fog, anxiety attack, muscle ache and felt awful were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
weakness, lightheadedness, heart racing, BP 140/90, T99.4 (taken by school nurse);saw NP no tx given;
No symptoms have occurred. My 6 year old daughter received her 2nd Pfizer dose on 2/19/22. At approximately 3:39pm, I received a phone call from the pharmacy where the injection was given. The technician informed me that my daughter received the incorrect vaccine. That she may have more severe reactions this time, post vaccine. Today, 2/21, I called the pharmacy to attempt to obtain a copy of the health and safety report that the technician said that she filled out. She said that she would have to check with her supervisor. I got a call back stating that they weren't able to provide this with me. I also asked her if the lot number was correct, due to the lot number being the same as my daughter's first dose. She said that when companies get large shipments, it is quite possible. I then get a phone call from her again at 10:21am asking what the lot number that she wrote down was. Something seemed off, so I called back and informed her that I didn't have the vaccine card in front of me, but asked what lot number she had and scanned. Low and behold, they are completely different lot numbers. This report is being made to make awareness that this pharmacy practices complete medical negligence. Not only by the administration of the incorrect dose to a child, but also not putting correct lot numbers onto cards that are scanned on the viles.